Inhibin β-A (INHBA) Induces Epithelial-mesenchymal Transition and Accelerates the Motility of Breast Cancer Cells by Activating the TGF-β Signaling Pathway

Overview

Journal Bioengineered

Date 2021 Aug 4

PMID 34346300

Citations 29

Authors

Yingying Yu

Weiwei Wang

Wenying Lu

Wei Chen

Anquan Shang

Affiliations

Soon will be listed here.

Abstract

Accumulating evidence indicates that INHBA (Inhibin β-A, a member of the TGF-β superfamily) functions as an oncogene in cancer progression. However, little is known as to how INHBA regulates the progression and aggressiveness of breast cancer (BC). This study explored the function and underlying mechanism of INHBA in epithelial-mesenchymal transition (EMT) of BC cells. INHBA expression in BC cell lines was measured using RT-qPCR and Western blot. The would-healing and transwell migration assays were used to investigate the effect of INHBA overexpression or silencing on BC cell motility. Moreover, the expression levels of EMT-related genes were quantified after overexpressing or silencing of INHBA. Based on published dataset, INHBA was significantly upregulated in BC tissues compared to the adjacent normal tissues. A higher level of INHBA expression was also correlated with a poor survival in BC patients. In addition, study showed that INHBA played an indispensable role in promoting BC cell proliferation and invasion. Mechanistically, INHBA induced epithelial-mesenchymal transition (EMT) and accelerated the motility of BC cells by activating TGF-β-regulated genes. In conclusion, INHBA plays a functional role in supporting EMT phenotype of BC cells, and it may serve as a diagnostic biomarker and a potential therapeutic target for BC treatment.

Citing Articles

Genome-wide CRISPR/Cas9 screening identifies key profibrotic regulators of TGF-β1-induced epithelial-mesenchymal transformation and pulmonary fibrosis.

Tan C, Wang J, Ye X, Kasimu K, Li Y, Luo F Front Mol Biosci. 2025; 12:1507163.

PMID: 40034336 PMC: 11872725. DOI: 10.3389/fmolb.2025.1507163.

Comprehensive analysis of inhibin-β A as a potential biomarker for gastrointestinal tract cancers through bioinformatics approaches.

Verma R, Srivastava P, Singh A Sci Rep. 2025; 15(1):1090.

PMID: 39774945 PMC: 11707248. DOI: 10.1038/s41598-024-72679-3.

Machine-learning derived identification of prognostic signature to forecast head and neck squamous cell carcinoma prognosis and drug response.

Li S, Sun H, Tian Y, Zhou L, Zhou T Front Immunol. 2025; 15:1469895.

PMID: 39749326 PMC: 11693666. DOI: 10.3389/fimmu.2024.1469895.

Mitogen-Activated Protein Kinase Phosphatase-5 is Required for TGF-β Signaling Through a JNK-Dependent Pathway.

Dorry S, Perla S, Bennett A Mol Cell Biol. 2024; 45(1):17-31.

PMID: 39607740 PMC: 11693473. DOI: 10.1080/10985549.2024.2426665.

Prognostic Value of TGF-β Expression in Bladder Cancer: A Systematic Review and Meta-analysis.

Kianmehr S, Vahabirad M, Seghatoleslam A, Sadeghi E, Kiani R, Ghasemi H Urol Res Pract. 2024; 50(3):148-153.

PMID: 39495544 PMC: 11562745. DOI: 10.5152/tud.2024.24024.

References

Wang Q, Wen Y, Li D, Xia J, Zhou C, Yan D . Upregulated INHBA expression is associated with poor survival in gastric cancer. Med Oncol. 2010; 29(1):77-83. DOI: 10.1007/s12032-010-9766-y. View

Fagone P, Mangano K, Pesce A, Portale T, Puleo S, Nicoletti F . Emerging therapeutic targets for the treatment of hepatic fibrosis. Drug Discov Today. 2015; 21(2):369-75. DOI: 10.1016/j.drudis.2015.10.015. View

Yang J, Weinberg R . Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008; 14(6):818-29. DOI: 10.1016/j.devcel.2008.05.009. View

Li X, Yang Z, Xu S, Wang Z, Jin P, Yang X . Targeting INHBA in Ovarian Cancer Cells Suppresses Cancer Xenograft Growth by Attenuating Stromal Fibroblast Activation. Dis Markers. 2019; 2019:7275289. PMC: 6885285. DOI: 10.1155/2019/7275289. View

Eroles P, Bosch A, Perez-Fidalgo J, Lluch A . Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev. 2011; 38(6):698-707. DOI: 10.1016/j.ctrv.2011.11.005. View

Wei C, Li Y, Zhu Z, Jia D, Fan M, Li T . Inhibition of activator protein 1 attenuates neuroinflammation and brain injury after experimental intracerebral hemorrhage. CNS Neurosci Ther. 2019; 25(10):1182-1188. PMC: 6776742. DOI: 10.1111/cns.13206. View

Okano M, Yamamoto H, Ohkuma H, Kano Y, Kim H, Nishikawa S . Significance of INHBA expression in human colorectal cancer. Oncol Rep. 2013; 30(6):2903-8. DOI: 10.3892/or.2013.2761. View

Guarino M . Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Biol. 2007; 39(12):2153-60. DOI: 10.1016/j.biocel.2007.07.011. View

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

10.

Imamura T, Hikita A, Inoue Y . The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis. Breast Cancer. 2011; 19(2):118-24. DOI: 10.1007/s12282-011-0321-2. View

11.

Hao Y, Baker D, Ten Dijke P . TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int J Mol Sci. 2019; 20(11). PMC: 6600375. DOI: 10.3390/ijms20112767. View

12.

Nicoletti F, Di Marco R, Patti F, Reggio E, Nicoletti A, Zaccone P . Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b). Clin Exp Immunol. 1998; 113(1):96-9. PMC: 1905006. DOI: 10.1046/j.1365-2249.1998.00604.x. View

13.

Bashir M, Damineni S, Mukherjee G, Kondaiah P . Activin-A signaling promotes epithelial-mesenchymal transition, invasion, and metastatic growth of breast cancer. NPJ Breast Cancer. 2017; 1:15007. PMC: 5515205. DOI: 10.1038/npjbcancer.2015.7. View

14.

Hortobagyi G . Treatment of breast cancer. N Engl J Med. 1998; 339(14):974-84. DOI: 10.1056/NEJM199810013391407. View

15.

Chen Z, Qin L, Peng X, Hu Y, Liu B . INHBA gene silencing inhibits gastric cancer cell migration and invasion by impeding activation of the TGF-β signaling pathway. J Cell Physiol. 2019; 234(10):18065-18074. DOI: 10.1002/jcp.28439. View

16.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

17.

Peng S, Wang J, Hu P, Zhang W, Li H, Xu L . INHBA knockdown inhibits proliferation and invasion of nasopharyngeal carcinoma SUNE1 cells in vitro. Int J Clin Exp Pathol. 2020; 13(5):854-868. PMC: 7270653. View

18.

. Comprehensive molecular portraits of human breast tumours. Nature. 2012; 490(7418):61-70. PMC: 3465532. DOI: 10.1038/nature11412. View

19.

Kim H, Watkinson J, Varadan V, Anastassiou D . Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics. 2010; 3:51. PMC: 2988703. DOI: 10.1186/1755-8794-3-51. View

20.

Brown C, Woodruff T, Matzuk M . Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat Genet. 2000; 25(4):453-7. DOI: 10.1038/78161. View